their careers, pausing only briefly for childbirth, then returning at least part time. Almost 50% of mothers with a child 1year of age or less return to the labor force (Young, 1986) . Sixty percent of the women with children under the age of 3 years return to the work force full time after childbirth (Heath, 1986) .
Kay is a 30-year-old computer programmer. Monthly, she goes through cyclic changes that she attribu tes to premenstrual syndrome: breast tenderness, bloating, increased appetite, and lower back pain. On some days, her symptoms are severe enough that she considers missing work, but fears that this would affect her chances for promotions. Instead, she takes one Librium (chlordiazepoxide) and goes to work. Kay is 25% over her ideal body weight, consumes a diet high in sodium and fats, leads a sedentary life, and has not had a gynecological examination in 3 years. The occupational health nurse at her company instructed her to keep track of her symptoms daily. After 2 months, the nurse reviewed her daily diary. It was apparent that she indeed experienced PMS as well as dysmenorrhea.
The common denominator for the majority of working women is that they are menstruating. Up to 90% of women are estimated to experience menses-related symptoms that can result in mild to severe discomfort, ultimately having the potential to affect productivity or increase absenteeism (Abraham, 1978b) .
Menstrual Cycle
The normal menstrual cycle is characterized by cyclic rhythmic changes of the hormones, ovaries, and uterus. The duration of the cycle ranges between 20 and 4S days (Figure 1 ). The menstrual cycle begins day 1 with the onset of menses, resulting from the desquamation of the endometrium. The two types of ovarian sex hormones are estrogens and progesterones. During days 1 through 5, both of these hormones are at low levels. Estrogens promote proliferation of cells, so as the level rises, the follicle develops over days 6 through to, while the progesterones remain at a lower level.
Ovulation occurs between 11 to 15 days into the cycle, concluding the follicular phase and beginning the luteal phase of the menstrual cycle. If fertilization does not occur, the endometrium continues to thicken, and the estrogens drop substantially. The progesterones, which prepare the uterus and breasts for pregnancy, peak around days 21 to 25. The follicle develops into the corpus lutem.
Gradually, the hormone levels lower, as the uterus prepares for menses around day 28. As a result of these cyclic changes and other hormonal swings, various menstrual related symptoms are experienced by women (Abraham, 1978b; Guyton, 1986) . that occur in the luteal phase of the menstrual cycle, varying from 2 to 12 days before the onset of menses, and resolving within the first 24 hours of flow. Symptoms vary from food cravings, breast tenderness, dull pelvic pain , bloating, and nervousness to severe mood swings. These symptoms vary in intensity and duration. Estimates of the incidence ofPMS suggest that from 70 to 90% of menst ru a t ing women have recurrent symptoms, with severe symptoms reported by 20 to 40% (Kirkpatrick, 1985; Reid, 1981; Woods , 1982) . Treatment modalities include hormone therapy and other medications aimed at altering the existing symptoms. More recently, the focus has been on prevention of the symptoms through a healthier lifestyle. Monitoring diet intake alleviates some symptoms (Abraham, 1984) . The nutritional treatment approach is safe and sufficient in many cases, and it is often used initially for all clients with premenstrual symptomatology (Hargrove, 1983) . Exercise and stress management are other interventions with demonstrated effects (Canty, 1984; Coyne, 1983; O'Brien, 1985) .
Dysmenorrhea
In contrast to PMS, dysmenorrhea begins up to two days before menses during the follicular phase. Symptoms diminish within two to four days of menses, or may last to the end of menses. The degree of severity varies, occurring in 40 to 80% of women to some degree, and incapacitating 5 to 10% of all women (Jay, 1981) .
Dysmenorrhea is classified as either primary or secondary. Primary dysmenorrhea occurs within 1 to 3 years after menarche when ovulation begins. It escalates in severity into the mid to late 30s, then gradually diminishes. Increased contractility of the myometrium, resulting in ischemia, causes the dysmenorrheic pain (Friederich, 1983) .Typically, the pain is characterized by sharp, intermittent, colicky pain located in the suprapubic region, radiating to the back and thighs. Extragenital side effects include headache, flushing, dizziness, syncope, palpitations, nausea, vomiting, diarrhea, and/or leg pains (Abraham, 1978a; Wilson, 1984) . Treatment has previously been focused on pain management with tranquilizers or narcotics.
More recently, the focus has shifted to prevention of symptoms through ovulation inhibiting combination oral contraceptives and prostaglandin synthesis inhibitors. Primary dysmenorrhea is most common in women who are nulliparous, obese, or have a sedentary lifestyle (Jay, 1983) . Perhaps increased exercise and appropriate nutrition would decrease adverse symptomatology in these women.
In contrast, secondary dysmenorrhea indicates a pathologic condition such as endometriosis, endometrial polyps, adenomyosis, fibroids, cervical stenosis, uterine prolapse, or pelvic inflammatory disease. The pain is characterized as constant, dull, and diffuse bilateral or unilateral lower abdominal pain. Dyspareunia and changes in the menstrual cycle may also occur. Treatment of secondary dysmenorrhea Up to 900k of women are estimated to experience menses related symptoms that can result in mild to severe discomfort, ultimately having the potential to affect productivity or increase absenteeism.
requires therapeutic resolution of the underlying pathology (Abraham, 1978a; Wilson, 1984) . No evidence suggests that healthier lifestyle changes would help decrease the pain associated with secondary dysmenorrhea.
Based on previous research findings, this study hypothesized that women with either PMS or primary dysmenorrhea who initiate healthier lifestyle patterns would demonstrate fewer and/or less severe menstrual related symptoms. Basic nutrition practices were a targeted intervention.
RESEARCH QUESTIONS
Questions for the study were:
• Is there a correlation between premenstrual and dysmenorrheic symptoms regarding number of daily occurrences of symptoms and number of severe symptoms? • Do participants in a premenstrual syndrome education program (PSEP) report a decrease in occurrences and severity of premenstrual symptoms? • Do participants in a PSEP report a decrease in occurrences and severity of dysmenorrheic symptoms?
METHODOLOGY
Subjects were recruited from a population of female employees at the corporate headquarters for an oil company. Participants in the study were 25-to 50-year-old employees who were not pregnant and were having regular menstrual cycles. In addi-tion, participants had to have moderate to severe premenstrual symptoms as measured by Abraham's (1983) menstrual symptomatology questionnaire (MSQ). Of approximately 540 female employees in this age range, 118 (22%) returned the MSQ and met participant criteria. Of these, 86 (73%) qualified for the study and 65 (76%) agreed to participate in the study. After 18 of the women who began the study dropped out during the first data gathering stage, 47 (72%) remained in the final study sample.
Subjects were randomly assigned with 24 in the control group and 23 in the experimental group. The sample size was sufficient to detect large effects at alpha = 0.05 with a power of .8 (Cohen, 1977) . Statistical tests revealed that the experimental and control groups were similar as related to age, education, ethnic group, religion, marital status, frequency of sexual intercourse, number of pregnancies, age at onset of menses, menstrual cycle length, and menstrual flow length.
The three instruments used in the study were the MSQ, the Menstrual Symptom Diary (MSD), developed by Abraham (1983) , and the demographic data form developed by the researchers for this study.
The MSQ was used as a screening tool to identify employees who had premenstrual symptoms, scoring moderate to severe in at least one of the symptom clusters included on the questionnaire. Nineteen symptoms were grouped into cluster categories of anxiety, appetite, edema, and depression. Responses on the MSQ were based on the woman's retrospective report of her symptoms during her previous menstrual cycle.
Data for the study were collected on the MSD and the demographic data form. The MSD is a chart listing the same 19 premenstrual symptoms used on the MSQ, grouped into the four clusters. In addition, the MSD includes a dysmenorrheic painrelated symptom group for recording symptoms especially characteristic of the menses phase of the cycle. Groupings of the premenstrual dys-menorrheic symptoms are shown in Figure 2 .
Scores for occurrences were calculated from the MSD data by counting all symptoms reported during each menstrual phase. Severity was calculated by counting only moderate and severe symptoms during each menstrual phase. Premenstrual symptoms were calculated for seven days prior to onset of menstruation, and dysmenorrheic symptoms were calculated for the days of menstrual flow.
Once selected, subjects recorded the symptoms listed on the MSD daily for three menstrual cycles. Data recorded during the first cycle were used to determine the correlation between premenstrual and menses phase symptoms, and to provide baseline data for covarying the third cycle data when comparing the experimental and control groups at the end of the study.
The experimental group participated in a PSEp, consisting of two 45minute class sessions presented on consecutive days during the noon hour in the work setting. Class content included basic physiology of the menstrual cycle, general information about PMS, dysmenorrhea, and different treatment modes focusing primarily on the dietary approach. Dietary guidelines designed for persons with PMS were used in the class (Abraham, 1983) .
A booklet and other handouts were given to PSEP participants to reinforce class content. Practical suggestions for implementing dietary changes were discussed. Other treatments, such as exercise, stress management, and hormone therapy and other medications, were more briefly discussed.
RESULTS
The correlations between premenstrual and dysmenorrheic symptom clusters were calculated to answer the first study question. Statistically significant positive correlations between the occurrences of premenstrual and dysmenorrheic symptoms in anxiety (r=.31, p=.03), appetite (r=.30, p=.01), and edema Evidence suggests that certain healthy lifestyle actions can diminish the discomforts ofPMS.
(r= .45, p= .01) clusters were demonstrated. This means that women who reported symptoms in the anxiety, appetite, and edema clusters did not exclusively experience these in the premenstrual phase, but also during their menstrual flow. Significant positive correlation between symptoms that were severe in the edema (r=.34, p=.02) and depression (r=.34, p=.02) clusters was also demonstrated. Once again, in terms of severity, those women whose symptoms clustered into the edema and the depression categories exhibited them both prior to and during menstrual flow.
To answer the second study question about the effect of PSEP on the occurrences and severity of premenstrual symptomatology, symptoms recorded during the women's third menstrual cycle were compared using analysis of covariance (ANCOVA). The means for occurrences and severity of the four premenstrual symptom clusters during the premenstrual phase at the end of the study are presented in Table 1 .
Means for PMS symptoms were based on the total symptoms reported for the seven day premenstrual phase.
The study groups had significant differences in the anxiety (F=5.43, p=.03) and appetite (F=4.09, p=.05) symptoms, with the experimental group significantly lower in occurrences of any of these premenstrual symptoms during the last menstrual cycle in the study. Women who attended the PSEP classes reported less symptoms in the anxiety and appetite clusters than those Booton, Seideman women who did not attend the classes.
The differences between the experimental and control groups in occurrences of edema (F=1.16, p=.29) and depression (F=.02, p=.90) symptoms were not statistically significant.
Differences between the experimental and control groups in the number of more severe premenstrual symptoms were also examined. The experimental and control groups had significant differences in the edema (F=7.01, p=.007) symptoms, with the experimental group having fewer severe edema symptoms. Again, women experienced less severe edema symptoms after they attended the PSEP class.
The anxiety (F=.29, p=.59), appetite (F=.22, p=.64), and depression (F=2.32, p=.14) premenstrual symptoms showed no significant differences between the experimental and control groups.
To answer the third study question, dysmenorrheic symptoms of the control and experimental groups were compared after the experimental group had participated in the PSEP. The means for occurrences and severity of menses phase symptoms at the end of the study are shown in Table 2 .
Means for dysmenorrheic symptoms were based on symptoms per day, since the number of days in the menses phase varied among women in the study. No significant differences existed between these groups in any of the symptom clusters when occurrences of all daily symptoms were compared or when only the more severe symptoms were compared.
On the MSD, the four clusters representing the 19 symptoms are classically associated with PMS. The fifth cluster represents pain symptoms during menses, classically representing dysmenorrhea. In this study, women in the experimental group who attended the PSEP classes showed less PMS symptoms, but indicated no improvement for dysmenorrhea, even on the cluster classically associated with dysmenorrhea. gram primarily focusing on nutrition resulted in a corresponding improvement of PMS and dysmenorrhea. Certain premenstrual symptom clusters were improved both in severity and occurrence. In contrast, dysmenorrheic symptoms were not minimized. PMS and dysmenorrhea appear to be different entities, requiring different treatment modalities.
RECOMMENDATIONS
The wide range of health care provided by occupational health nurses has been reported to decrease health symptoms may be the same.
No attempt was made to differentiate whether the women had primary or secondary dysmenorrhea. Primary dysmenorrhea is more prevalent than secondary dysmenorrhea. The age group of the women in this study is more characteristic of those who would have primary dysmenorrhea. For these reasons, the researchers assumed that most dysmenorrheic symptoms reported in this study would be from primary dysmenorrhea.
In summary, this study did not demonstrate that an educational pro-
CONCLUSIONS
The correlations of specific symptoms reported in the premenstrual phase with those in the menses phase indicate that these women often experience some of the same symptoms at both times in the menstrual cycle. One explanation may be that some women tend to have premenstrual symptoms that continue during the first or second day of menses. Another explanation might be that general symptoms such as aches and pains, anxiety, or fatigue occur with either PMS or dysmenorrhea, although caused by different pathology. Although PMS and dysmenorrhea differ physiological1y, reported interventions to decrease the sequelae are the same.
The literature suggests that obese women with a sedentary lifestyle have a greater prevalence of dysmenorrhea. In comparison, research supports that improvement of nutrition and exercise reduce the severity and/or occurrence of PMS. This study supported the latter, demonstrating an improvement of PMS in certain women whose symptoms congregated around anxiety, edema, or appetite. In contrast, these same women did not demonstrate less dysmenorrhea. This indicates even more clearly that PMS and dysmenorrhea are indeed different entities, although personal characteristics and insurance claims, reduce health insurance costs, decrease absenteeism, improve worker productivity, and improve morale, as well as contribute to a healthier workplace (Dellinger, 1986) .
PMS and dysmenorrhea are health problems that can influence these markers of working women's health. Nurses can collect the basic assessment data, evaluate the employee if secondary dysmenorrhea is suspected, and provide the education and support that will help diminish or resolve symptomatology related to the menstrual cycle. The importance of obtaining thorough information about the menstrual health of these women cannot be overemphasized. The daily diary of symptoms is an invaluable tool to assess baseline data of severity, duration, and location in the cycle. As women participate in self care activities such as improving nutrition, the daily diary can provide evidence of the impact on symptomatology. This can also provide reinforcement for changing health practices and guide anticipatory interventions to minimize symptoms. In the event that a referral to another health care provider is indicated, the documented symptom history can expedite the assessment, interventions, and return to the maximum level of health.
Kay participated in this study and was randomly assigned to the experimental group.Afterthe completion of the PSEP classes, she continued to document her symptoms in her daily diary for 1month. At that time, a 24-hour diet recall indicated a decrease in dietary fats and salt. She had begun a walking exercise program. A 5 Ib weight lossoccurred over this 4-week time frame. In reviewing her premenstrual symptomatology, she had less severe and less frequent symptoms. This was a welcome respite. However, Kay remained symptomatic with low back pain and lower abdominal fullness during days 1 through 4 of her menstrual flow. At her workplace she had been evaluated, instructed in self care measures to improve her symptoms, and referred for a more thorough evaluation and specific treatment of her dysmenorrhea.
Based on the similar symptomatology, occurring at slightly different days of the menstrual cycle, the present study lends support to the need for continued prospective studies which distinguish women experiencing premenstrual syndrome from those experiencing dysmenorrhea. Also, it would be necessary to differentiate between women who have primary dysmenorrhea and those who have secondary dysmenor-rhea. Those who are symptomatic during both menstrual phases constitute yet another group for investigation.
Estimates of the incidence of PMs suggest that from 70 to 90% of menstruating women have recurrent symptoms, with severe symptoms reported by 20 to 40%.
